Oncothyreon, Inc. is a biotechnology company founded in 1985 with a dedication to the development of oncology products aimed at improving the lives and outcomes of cancer patients. The company's focus lies in the development of therapeutic candidates, including synthetic vaccines and small molecules, designed to target cancer in specific and effective ways. With a primary focus on Biotechnology and Health Care industries, Oncothyreon is positioned at the forefront of innovative cancer treatment solutions.
General Information
Get notified when Oncothyreon, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Oncothyreon, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Oncothyreon, Inc.
No funding data available for Oncothyreon, Inc. yet.
Get notified when Oncothyreon, Inc. raises fundingOncothyreon, Inc. Alternatives & Competitors
Every minute, every hour, every day we’re working towards a cancer free future.
Colorado’s only National Cancer Institute-Designated Comprehensive Cancer Center.
Cancer research, care, and education at the University of Utah. NCI-Designated Comprehensive Cancer...
FAQ About Oncothyreon, Inc.
Don't just browse. Track.
Signal Tracker monitors Oncothyreon, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.